Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients
Not applicable · Testing Virtual reality-directed BGBT · 1 site · University of Michigan
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing Virtual reality-directed BGBT (a device) as a possible treatment. Condition(s) listed: Inflammatory Bowel Diseases.
It is open-label: participants know what they are receiving.
This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Patients with Inflammatory Bowel Disease and self-reported pain
- Hospitalized for management of IBD (inpatient medicine services at Michigan Medicine)
There are also 6 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 40 participants are expected to take part.
- Start date: 2024-02-13.
- Main results expected around 2026-09 (estimate from the record).
- 1 study site listed (1 marked recruiting) in United States.
Main thing being measured
- Feasibility of the intervention measured as the frequency (percentage) of enrolled participants that complete the VR-directed BGBT inpatient program (3 days of treatment)
In the researchers’ words
The research is studying virtual reality (VR)-directed brain-gut behavioral therapy (BGBT) as a pain treatment option for hospitalized patients with inflammatory bowel disease (IBD). This study is being done to learn if VR-directed BGBT is feasible and acceptable for patients with IBD in addressing pain in the hospital setting.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Not applicable |
| Study type | Interventional |
| Conditions | Inflammatory Bowel Diseases |
| Lead sponsor | University of Michigan |
| Enrollment | 40 (estimated) |
| Start date | 2024-02-13 |
| Primary completion (est.) | 2026-09 |
| First posted | 2024-01-03 |
| Last updated | 2026-07-23 |
| Official title | Evaluation of a Virtual Reality-Directed Brain Gut Behavioral Treatment Inpatient Program for Patients With Inflammatory Bowel Disease |
| ClinicalTrials.gov ID | NCT06188793 |
Interventions
- Virtual reality-directed BGBT (Device)
Enrolled participants will receive up to 3-days of VR-directed BGBT through several modules including distraction games, mindfulness meditation, breathing exercises, and cognitive behavioral therapy based coaching. Participants will complete questionnaires at various time points and be asked to complete a semi-structured interview post-intervention.
Full eligibility criteria (from the record)
Inclusion Criteria: * Patients with Inflammatory Bowel Disease and self-reported pain * Hospitalized for management of IBD (inpatient medicine services at Michigan Medicine) Exclusion Criteria: * Patients that do not report pain * Anticipated length of hospital stay is less than 72 hours * Patients that have previously had a seizure, loss of awareness, or other symptoms linked to an epileptic condition * Patients with binocular vision loss * Patients with an uncontrolled cardiac condition such as an arrhythmia, coronary artery disease, or neurological/cerebrovascular disease. * Patients that are currently pregnant
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| University of Michigan | Ann Arbor, Michigan | United States | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.